Visa marks Earth Day 2021 with industry-leading milestones, innovative partnerships and initiatives toward its vision of a sustainable future

SAN FRANCISCO-Thursday 22 April 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Visa (NYSE: V), a leading global payments technology company, announced today a new global commitment to reach net-zero emissions by 2040, and that the company achieved carbon neutrality across its operations in 2020.i Visa also outlined plans to become a climate positive company through new partnerships and expanded initiatives to support sustainable commerce and the transition to a low-carbon economy beyond the company’s own footprint.

“Visa is committed to creating a more sustainable future,” said Al Kelly, chairman and chief executive officer of Visa. “Our new net-zero commitment and enhanced efforts across our network in support of sustainable initiatives are immediate ways we will achieve our goals to help build a better ... Read more »

 BALLERUP, Denmark, & MADISON, N.J.-Friday 23 April 2021 [ AETOS Wire ]

 

• Interim analysis at 56 weeks from ECZTEND, an open-label extension trial, demonstrates sustainable and durable efficacy of tralokinumab in adult patients1
• Patients enrolled in ECZTRA 1 and 2 parent trials who continued into ECZTEND have now been treated with tralokinumab for two years1
• The overall safety profile of tralokinumab was consistent with that observed in the parent trials1

(BUSINESS WIRE) -- LEO Pharma A/S, a global leader in medical dermatology, today announced results on the long-term safety and efficacy profile of tralokinumab in adult patients with moderate-to-severe atopic dermatitis. Results were shared as an oral presentation during the American Academy of Dermatology Virtual Meeting Experience (AAD VMX) 2021.

Tr ... Read more »

• Every US 30 Cent donation will provide one meal for someone in need

• Beneficiary countries include Uganda, Ghana, Angola, Sierra Leone, Sudan, Egypt, Somalia, Kenya, Mauritania, and Tanzania

DUBAI, United Arab Emirates-Thursday 22 April 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Low-income families and individuals in 10 African countries including Uganda, Ghana, Angola, Sierra Leone, Sudan, Egypt, Somalia, Kenya, Mauritania, and Tanzania, will receive food parcels throughout the holy month of Ramadan, as part of the ‘100 Million Meals’ campaign launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai.

The region’s biggest food donation drive aims to raise $27 million to distribute food parcels that are sufficient to prepare 100 million meals across 20 countries in the Middle East, Africa and Asia.

To ensure a swift and integrated food distribution ... Read more »

NEW YORK-Thursday 22 April 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today its collaboration with Royalty Pharma plc (Nasdaq: RPRX), the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, to expand MSCI’s thematic index suite with the launch of new indexes that aim to capture long-term, cutting edge themes that will disrupt the life sciences, biotechnology and pharmaceutical industry groups.

The initial indexes will measure the performance of companies focused on delivering new and innovative therapeutic treatments related to virology and oncology. Royalty Pharma will provide expertise on various medical conditions, clinical trials, transformative therapies and technologies that may lead to breakthrough medical treatments that will assist MSCI to design a class ... Read more »

Not for Release, Publication or Distribution in the United States, Australia, Canada, Japan or Nigeria

LAGOS, Nigeria-Friday 23 April 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- In a sign of robust global investor interest in the continent, Africa Finance Corporation, a multilateral development financial institution dedicated to infrastructure financing in Africa, successfully issued a Eurobond at its lowest yield to date.

The US$750 million 2.875% 144a/ Reg S Notes due 2028 were priced at 175 bps over US Treasuries to yield 2.991%. The Corporation has progressively reduced its funding cost on dollar benchmark issuances with a shorter dated 5-year US$700 million Eurobond in 2020 at 3.250%, a 10-year US$500 million Eurobond in November 2019 at 3.895% and a 7-year US$650 million Eurobond in June 2019 at 4.500%.

AFC is focused on bridging Africa's large infrastructure deficit by financing projects that have high developmental impact on the economies of Af ... Read more »

Open Technology Platform Gives Direct and Flexible Access to High-Value Travel & Aviation Data All in One Place
 

LONDON-Thursday 22 April 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- OAG, the world’s leading provider of travel data and insight, today announced the launch of OAG Metis, its new game-changing technology platform. Powered by Microsoft Azure and Snowflake, the platform will enable customers to scale confidently, adapt and innovate.

OAG Metis is an open platform with access to a blended and configurable view of high-value flight information, including airline schedules and flight status. It is also the home to new, unique, and proprietary content. By blending multiple data sources within a single platform, OAG is enabling the entire travel ecosystem to make better decisions and spark innovation.

The new technology platform gives customers the data they want, when they want it, in their preferred delivery mechanism (Alerts, AP ... Read more »

NOT FOR DISTRIBUTION IN THE UK OR IRELAND

BALLERUP, Denmark-Friday 23 April 2021 [ AETOS Wire ]

 If authorized, Adtralza® (tralokinumab) will be the first approved biologic that specifically targets the IL-13 cytokine, a key driver of atopic dermatitis signs and symptoms1,2
The CHMP opinion is primarily supported by data from ECZTRA 1, 2, and 3 trials included in the Marketing Authorization Application
 

(BUSINESS WIRE) -- LEO Pharma A/S, a global leader in medical dermatology, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization of Adtralza® (tralokinumab) for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy.

The CHMP positive opinion is one of the final steps before the European Commission makes its deci ... Read more »